STARTUP PROFILE

Cadence Neuroscience

COUNTRY
USA
FOUNDED
2017
CATEGORY
Neuromodulation
Developing an implantable neuromodulation therapy for drug-resistant focal epilepsy using personalized cortical stimulation and brain-activity monitoring.
Visit website →
Neurofounders Insights
$   Funding   -
Series B
MODALITY
Multimodal
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Epilepsy
TARGET USER
Patients
REGULATORY STAGE
Investigational
Cadence Neuroscience sits in the implanted epilepsy neuromodulation segment, with chronic subthreshold cortical stimulation used to personalize therapy around patient-specific brain activity. Its positioning is differentiated by a reversible cortical stimulation approach for focal drug-resistant epilepsy, placing it alongside established implantable epilepsy therapies while using a distinct stimulation strategy.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Cadence Neuroscience
No items found.